States Will Watch How Industry Payments To Docs Change With Sunshine Act
State regulators will be watching for changes in the payments pharmaceutical companies make to physicians once federal legislation is passed requiring disclosure, New York State Medicaid Inspector General Jim Sheehan said at the National Disclosure Summit
You may also be interested in...
Increased pre-emption under the Physician Payment Sunshine Act is possible if the federal law is expanded to include all or most provisions under state disclosure laws, Senate Finance Committee Investigative Counsel Christopher Armstrong said at the National Disclosure Summit in Washington, D.C
The International Fragrance Association North America took a break from its higher-stakes advocacy work Nov. 1 to give lawmakers and congressional staffers a "scent experience." Perfumers from six of the group's biggest members were on hand with "Scents of Home," joined by Monell Center researchers to educate attendees on the mechanics of scent and the important role it plays in people's lives.